Form D · Biotechnology
inSoma Bio, Inc.
Durham, NC · CIK 0001814250
Offering snapshot reported Jan 22, 2026 · SEC filing
- Reported sold
- $2.69M Offering amount: $4M
- Investors reported
- 15 Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Sep 24, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 22, 2026 | Amendment | $2,689,372 | No comparison | 15 | SEC filing |
| Oct 20, 2025 | Initial | $1,925,572 | No comparison | 8 | SEC filing |
| May 6, 2024 | Amendment | $2,720,749 | $606,202vs Jun 29, 2023 | 16 | SEC filing |
| Jun 29, 2023 | Amendment | $2,114,547 | $1,009,547vs May 1, 2023 | 9 | SEC filing |
| May 1, 2023 | Initial | $1,105,000 | No comparison | 3 | SEC filing |
| Dec 1, 2020 | Amendment | $1,273,675 | $93,675vs Nov 9, 2020 | 31 | SEC filing |
| Nov 9, 2020 | Amendment | $1,180,000 | $795,000vs Oct 26, 2020 | 29 | SEC filing |
| Oct 26, 2020 | Amendment | $385,000 | $335,000vs Sep 3, 2020 | 8 | SEC filing |
| Oct 13, 2020 | Amendment | $310,000 | $200,000vs Sep 17, 2020 | 5 | SEC filing |
| Sep 17, 2020 | Amendment | $110,000 | $60,000vs Sep 3, 2020 | 4 | SEC filing |
| Sep 3, 2020 | Initial | $50,000 | No comparison | 1 | SEC filing |
| Jul 9, 2020 | Initial | $202,000 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-561358
Source: Form D, filed Jan 22, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| June S. Almenoff | Director |
| Juliana Blum | Director |
| Heather Brennan | Director |
| Ashutosh Chilkoti | Director, Executive |
| Stefan Roberts | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
701 W. Main Street, Suite 410
Durham, NC, 27701
Durham, NC, 27701